- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06302686
engAGE: Managing cognitivE decliNe throuGh Theatre Therapy, Artificial Intelligence and Social Robots drivEn Interventions (engAGE)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The study is focused on older people with mild cognitive impairment, aiming to improve their quality of life and well-being, allowing them to preserve their identity, to reduce stress, memory loss, or communication challenges by the use of the technological engAGE system that includes the social robot Pepper. The social robot can be a great tool in engaging older adults in this kind of activities. It is always available and able to provide verbal clues or suggestions according to older adult's wishes, needs and memories. Moreover, the social robots may coach the older adults to perform daily activities with greater independence (i.e. coaching stepwise prompting to complete activities in-home) and support to caregivers as well.
Since caring for people with mild cognitive impairment puts a significant burden on informal caregivers, having the support of a technological platform can reduce anxiety, worries, and stress. The caregivers can personalize the content of interventions to the wishes and preferences of the older adults. Together with the older adults, they can be involved with the robot in joyful and fun activities like drama playing, storytelling, etc.
The formal caregivers who need to keep track of older adult progress which is a difficult and time-consuming process due to the lack of objective monitoring of cognitive decline and wellbeing may get valuable support from the cognitive assessment procedure implemented by the machine learning algorithm. Also, the social robot and tablet may facilitate the follow-up of older adults through reminders and cognitive interventions.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Anna Rita Bonfigli
- Phone Number: 0718003719
- Email: a.bonfigli@inrca.it
Study Locations
-
-
-
Ancona, Italy, 60127
- Recruiting
- IRCCS INRCA Hospital
-
Principal Investigator:
- Roberta Bevilacqua
-
Contact:
- Elvira Maranesi
-
-
-
-
-
Oslo, Norway
- Recruiting
- Karde A/S
-
Contact:
- Terje Grimstad
-
Principal Investigator:
- Terje Grimstad
-
-
-
-
-
Geneva, Switzerland
- Recruiting
- HUG
-
Contact:
- Christian Lovis
-
Principal Investigator:
- Christian Lovis
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- mild cognitive impairment (MCI);
- Montreal Cognitive Assessment (MoCA) score 21 - 25;
- Memory Assessment Clinics - Questionnaire (MAC-Q) ≥ 25;
- Reisberg scale 2 - 4;
- Clinical Frailty Scale score 1 - 3;
- 4-items GDS score ≤ 1;
- have an informal caregiver to support in carrying out the main daily activities.
Exclusion Criteria:
- lack of informal caregivers;
- significant visual or hearing impairment.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: engAGE group
The experimental group will use the technological engAGE system for 6 months.
|
The experimental group use the engAGE system at both healthcare organization and home.
At the healthcare organization, the subject interacts with Pepper robot.
The interaction is supervised by the formal caregivers and includes the following activities: dialoguing with the robot, storytelling, drama play, cognitive and physical games.
This interaction is planned to last about 1 hour twice a week for 6 months.
At home, the older user interacts with the tablet supervised by the informal caregiver.
The user plays cognitive and physical games installed on MEMAS app.
This activity is performed for 0.5 hour, every day for 6 months.
Throughout the whole period of experimentation, the older user wears the smartwatch that measures his/her physiological parameters and the steps.
Any activity performed by the seniors is assigned by formal caregiver and can be personalized taking into account the user's abilities, lifestyle, and social interactions.
|
Other: control group
To the control group will be given a booklet containing information and activities on well-being to do at home.
|
To the control group will be given a booklet containing information and activities on well-being to do at home.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in perceived stability of cognitive status by the older adults
Time Frame: baseline and 6 months later
|
The Memory Assessment Clinics - Questionnaire (MAC-Q) is a 6-item scale that uses a 5-item Likert scale from "much better now"=1 to "much worse now"=5, and the last question scores double.
The questionnaire asks the person to compare his or her memory with a previous period to measure age-related memory decline.
Five items address specific situations frequently reported as problematic by those who experience memory loss with age.
One item is a global item assessing general memory decline.
A cutoff of 25 points or more indicates that the individual has a memory disorder.
|
baseline and 6 months later
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in cognitive impairment in older adults
Time Frame: baseline and 6 months later
|
The Montreal Cognitive Assessment (MoCA) is a screening assessment for detecting cognitive impairment.
The MoCA assesses several cognitive domains: the short-term memory recall task (5 points), visuospatial abilities (4 points), alternation task (1 point), verbal abstraction task (1 point), attention, concentration, and working memory (6 points), language (6 points), abstract reasoning (2 points), and orientation to time and place (6 points).Scores on the MoCA range from zero to 30.
A score of 26 and higher is considered normal.
|
baseline and 6 months later
|
Change in depression in older adults
Time Frame: baseline and 6 months later
|
The 4-items Geriatric Depression Scale (GDS) is a 4-items scale whose answers are yes or no.
If all the items are answered negatively then the depression is excluded; if only one item is answered positively then the situation is uncertain; if at least 2 items are answered positively, the patient is depressed.
|
baseline and 6 months later
|
Change in frailty status in older adults
Time Frame: baseline and 6 months later
|
The Clinical Frailty Scale (CFS) is a descriptive scale divides the older participants into 9 classes based on the information provided by them and their relatives: between 1 and 3 the patient is non-frail, pre-frail if 4, he is frail from 5 to 9.
|
baseline and 6 months later
|
Change in mental well being in older adults
Time Frame: baseline and 6 months later
|
The Warwick-Edinburgh Mental Wellbeing Scales (WEMWBS).
is used to enable the measuring of mental wellbeing in the general population.
The 12-item scale WEMWBS has 5 response categories, summed to provide a single score.
Scores range from 7 to 35 and higher scores indicate higher positive mental wellbeing.
|
baseline and 6 months later
|
Change in quality of life in older adults
Time Frame: baseline and 6 months later
|
The EuroQoL-5D-5L scale consists of five dimensions: mobility, independence, usual activities, pain/discomfort and anxiety/depression.
Each dimension has 5 levels: no problems, mild problems, moderate problems, severe problems and extreme problems.
The numbers from the five dimensions can be combined into a 5-digit number that describes the health status of the participant.
|
baseline and 6 months later
|
Change in acceptability of the engAGE system in older adults
Time Frame: baseline and 6 months later
|
Acceptability will be assessed by the Unified Theory of Acceptance and Use of Technology test (UTAUT). It's a standardized instrument for measuring the likelihood of success for new technology introductions and helps to understand the drivers of its acceptance. The questionnaire has 52 questions distributed in 4 key constructs: 1) performance expectancy, 2) effort expectancy, 3) social influence, and 4) facilitating conditions. Each question are based on a Likert-type 5-point scale ranging from 1 = strongly disagree to 5 = strongly agree. Increments are integers between 1 to 5. |
baseline and 6 months later
|
Change in quality of life in informal caregivers
Time Frame: baseline and 6 months later
|
The EuroQoL-5D-5L scale consists of five dimensions: mobility, independence, usual activities, pain/discomfort and anxiety/depression.
Each dimension has 5 levels: no problems, mild problems, moderate problems, severe problems and extreme problems.
The numbers from the five dimensions can be combined into a 5-digit number that describes the health status of the participant.
|
baseline and 6 months later
|
Change in mental well being in informal caregivers
Time Frame: baseline and 6 months later
|
The Warwick-Edinburgh Mental Wellbeing Scales (WEMWBS) is used to enable the measuring of mental wellbeing in the general population.
The 12-item scale WEMWBS has 5 response categories, summed to provide a single score.
Scores range from 7 to 35 and higher scores indicate higher positive mental wellbeing.
|
baseline and 6 months later
|
Change in caregiver burden
Time Frame: baseline and 6 months later
|
The Zarit Burden Interview (ZBI) is a caregiver self-report measure, containing 22 items.
Each item on the interview is a statement which the caregiver is asked to endorse using a 5-point scale.
Response options range from 0 (Never) to 4 (Nearly Always).
|
baseline and 6 months later
|
Collaborators and Investigators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- INRCA_004_2023
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mild Cognitive Impairment
-
University of California, San FranciscoNational Institute on Aging (NIA)Active, not recruitingMild Cognitive Impairment | Cognitive Decline | Cognitive Deterioration | Cognitive Impairment, Mild | Cognitive Deficits, MildUnited States
-
BaycrestCentre for Aging and Brain Health InnovationUnknownNeurocognitive Disorders | Cognitive Dysfunction | Mental Disorder | Cognitive Impairment, Mild | Cognitive Disorder | Nonamnestic Mild Cognitive ImpairmentCanada
-
Mackay Memorial HospitalBened Biomedical Co., Ltd.RecruitingMild Cognitive Impairment (MCI)Taiwan
-
Thomas Jefferson UniversityJohns Hopkins University; University of Pennsylvania; National Institute on Aging... and other collaboratorsCompletedMild Cognitive Impairment (MCI)United States
-
Palo Alto Veterans Institute for ResearchU.S. Army Medical Research and Development CommandCompletedAmnestic Mild Cognitive ImpairmentUnited States
-
Assaf-Harofeh Medical CenterNeurim Pharmaceuticals Ltd.UnknownMild Cognitive Impairment (MCI)Israel
-
Centre for Addiction and Mental HealthRecruitingAmnestic Mild Cognitive ImpairmentCanada
-
University of FloridaNational Institute on Aging (NIA)RecruitingAmnestic Mild Cognitive ImpairmentUnited States
-
Charite University, Berlin, GermanyCompletedMild Cognitive Impairment (MCI)Germany
-
Johns Hopkins UniversityNational Institute on Aging (NIA)CompletedMild Cognitive Impairment (MCI)United States
Clinical Trials on engAGE system
-
Weill Medical College of Cornell UniversityNational Institute of Mental Health (NIMH)Completed
-
Centre de Recherche de l'Institut Universitaire...Canadian Institutes of Health Research (CIHR); Rotman Research Institute at...Active, not recruitingSubjective Cognitive DeclineCanada
-
University of AlbertaAlberta Health servicesRecruitingNeurodevelopmental DisordersCanada
-
University of PittsburghNational Center for Advancing Translational Sciences (NCATS)Terminated
-
University of MichiganCompletedKnee OsteoarthritisUnited States
-
University of Nevada, Las VegasRecruitingMild Cognitive Impairment | Executive Dysfunction | Psychotherapy | Depression in Old AgeUnited States
-
University of RochesterNational Institute of Mental Health (NIMH)Completed
-
University of RochesterNational Institute on Aging (NIA)CompletedLoneliness | Social Isolation | Caregiver BurnoutUnited States
-
Queen's University, BelfastInvest NICompletedKnowledge, Attitudes, PracticeUnited Kingdom
-
University of Illinois at ChicagoNational Center for Advancing Translational Sciences (NCATS)Not yet recruitingDisabilities MultipleUnited States